Global Glycogen Synthase Kinase 3 Beta market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get Access Now!

Global Glycogen Synthase Kinase 3 Beta Market Size and Outlook 2025-31

The global Glycogen Synthase Kinase 3 Beta market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. United States market for Glycogen Synthase Kinase 3 Beta is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Glycogen Synthase Kinase 3 Beta is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Glycogen Synthase Kinase 3 Beta is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Glycogen Synthase Kinase 3 Beta players cover Mitsubishi Tanabe Pharma Corp, Neurim Pharmaceuticals Ltd, Actuate Therapeutics Inc, DiaMedica Therapeutics Inc, Angelini Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Glycogen Synthase Kinase 3 Beta Industry Forecast looks at past sales and reviews total world Glycogen Synthase Kinase 3 Beta sales in 2024, providing a comprehensive analysis by region and market sector of projected Glycogen Synthase Kinase 3 Beta sales for 2025 through 2031. With Glycogen Synthase Kinase 3 Beta sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glycogen Synthase Kinase 3 Beta industry. This Insight Report provides a comprehensive analysis of the global Glycogen Synthase Kinase 3 Beta landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glycogen Synthase Kinase 3 Beta portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Glycogen Synthase Kinase 3 Beta market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glycogen Synthase Kinase 3 Beta and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glycogen Synthase Kinase 3 Beta. This report presents a comprehensive overview, market shares, and growth opportunities of Glycogen Synthase Kinase 3 Beta market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; AP-001 &nbsp;&nbsp;&nbsp; AP-1 &nbsp;&nbsp;&nbsp; DM-204 &nbsp;&nbsp;&nbsp; Neu-120 &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Musculoskeletal Disorder &nbsp;&nbsp;&nbsp; Lung Cancer &nbsp;&nbsp;&nbsp; Dyskinesia &nbsp;&nbsp;&nbsp; Menkes Disease &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Mitsubishi Tanabe Pharma Corp &nbsp;&nbsp;&nbsp; Neurim Pharmaceuticals Ltd &nbsp;&nbsp;&nbsp; Actuate Therapeutics Inc &nbsp;&nbsp;&nbsp; DiaMedica Therapeutics Inc &nbsp;&nbsp;&nbsp; Angelini Group &nbsp;&nbsp;&nbsp; Jeil Pharmaceutical Co Ltd &nbsp;&nbsp;&nbsp; AMO Pharma Ltd Key Questions Addressed in this Report What is the 10-year outlook for the global Glycogen Synthase Kinase 3 Beta market? What factors are driving Glycogen Synthase Kinase 3 Beta market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Glycogen Synthase Kinase 3 Beta market opportunities vary by end market size? How does Glycogen Synthase Kinase 3 Beta break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Glycogen Synthase Kinase 3 Beta by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Glycogen Synthase Kinase 3 Beta by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Glycogen Synthase Kinase 3 Beta Segment by Type &nbsp;2.2.1 AP-001 &nbsp;2.2.2 AP-1 &nbsp;2.2.3 DM-204 &nbsp;2.2.4 Neu-120 &nbsp;2.2.5 Others &nbsp;2.3 Glycogen Synthase Kinase 3 Beta Sales by Type &nbsp;2.3.1 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Type (2020-2025) &nbsp;2.4 Glycogen Synthase Kinase 3 Beta Segment by Application &nbsp;2.4.1 Musculoskeletal Disorder &nbsp;2.4.2 Lung Cancer &nbsp;2.4.3 Dyskinesia &nbsp;2.4.4 Menkes Disease &nbsp;2.4.5 Others &nbsp;2.5 Glycogen Synthase Kinase 3 Beta Sales by Application &nbsp;2.5.1 Global Glycogen Synthase Kinase 3 Beta Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Glycogen Synthase Kinase 3 Beta Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Glycogen Synthase Kinase 3 Beta Breakdown Data by Company &nbsp;3.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Company (2020-2025) &nbsp;3.2.2 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Glycogen Synthase Kinase 3 Beta Sale Price by Company &nbsp;3.4 Key Manufacturers Glycogen Synthase Kinase 3 Beta Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Glycogen Synthase Kinase 3 Beta Product Location Distribution &nbsp;3.4.2 Players Glycogen Synthase Kinase 3 Beta Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Glycogen Synthase Kinase 3 Beta by Geographic Region &nbsp;4.1 World Historic Glycogen Synthase Kinase 3 Beta Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Glycogen Synthase Kinase 3 Beta Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Glycogen Synthase Kinase 3 Beta Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Glycogen Synthase Kinase 3 Beta Sales Growth &nbsp;4.4 APAC Glycogen Synthase Kinase 3 Beta Sales Growth &nbsp;4.5 Europe Glycogen Synthase Kinase 3 Beta Sales Growth &nbsp;4.6 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales Growth 5 Americas &nbsp;5.1 Americas Glycogen Synthase Kinase 3 Beta Sales by Country &nbsp;5.1.1 Americas Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025) &nbsp;5.1.2 Americas Glycogen Synthase Kinase 3 Beta Revenue by Country (2020-2025) &nbsp;5.2 Americas Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) &nbsp;5.3 Americas Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Glycogen Synthase Kinase 3 Beta Sales by Region &nbsp;6.1.1 APAC Glycogen Synthase Kinase 3 Beta Sales by Region (2020-2025) &nbsp;6.1.2 APAC Glycogen Synthase Kinase 3 Beta Revenue by Region (2020-2025) &nbsp;6.2 APAC Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) &nbsp;6.3 APAC Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Glycogen Synthase Kinase 3 Beta by Country &nbsp;7.1.1 Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025) &nbsp;7.1.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2020-2025) &nbsp;7.2 Europe Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) &nbsp;7.3 Europe Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Glycogen Synthase Kinase 3 Beta by Country &nbsp;8.1.1 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Glycogen Synthase Kinase 3 Beta &nbsp;10.3 Manufacturing Process Analysis of Glycogen Synthase Kinase 3 Beta &nbsp;10.4 Industry Chain Structure of Glycogen Synthase Kinase 3 Beta 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Glycogen Synthase Kinase 3 Beta Distributors &nbsp;11.3 Glycogen Synthase Kinase 3 Beta Customer 12 World Forecast Review for Glycogen Synthase Kinase 3 Beta by Geographic Region &nbsp;12.1 Global Glycogen Synthase Kinase 3 Beta Market Size Forecast by Region &nbsp;12.1.1 Global Glycogen Synthase Kinase 3 Beta Forecast by Region (2026-2031) &nbsp;12.1.2 Global Glycogen Synthase Kinase 3 Beta Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Glycogen Synthase Kinase 3 Beta Forecast by Type (2026-2031) &nbsp;12.7 Global Glycogen Synthase Kinase 3 Beta Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Mitsubishi Tanabe Pharma Corp &nbsp;13.1.1 Mitsubishi Tanabe Pharma Corp Company Information &nbsp;13.1.2 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications &nbsp;13.1.3 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Mitsubishi Tanabe Pharma Corp Main Business Overview &nbsp;13.1.5 Mitsubishi Tanabe Pharma Corp Latest Developments &nbsp;13.2 Neurim Pharmaceuticals Ltd &nbsp;13.2.1 Neurim Pharmaceuticals Ltd Company Information &nbsp;13.2.2 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications &nbsp;13.2.3 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Neurim Pharmaceuticals Ltd Main Business Overview &nbsp;13.2.5 Neurim Pharmaceuticals Ltd Latest Developments &nbsp;13.3 Actuate Therapeutics Inc &nbsp;13.3.1 Actuate Therapeutics Inc Company Information &nbsp;13.3.2 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications &nbsp;13.3.3 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Actuate Therapeutics Inc Main Business Overview &nbsp;13.3.5 Actuate Therapeutics Inc Latest Developments &nbsp;13.4 DiaMedica Therapeutics Inc &nbsp;13.4.1 DiaMedica Therapeutics Inc Company Information &nbsp;13.4.2 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications &nbsp;13.4.3 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 DiaMedica Therapeutics Inc Main Business Overview &nbsp;13.4.5 DiaMedica Therapeutics Inc Latest Developments &nbsp;13.5 Angelini Group &nbsp;13.5.1 Angelini Group Company Information &nbsp;13.5.2 Angelini Group Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications &nbsp;13.5.3 Angelini Group Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Angelini Group Main Business Overview &nbsp;13.5.5 Angelini Group Latest Developments &nbsp;13.6 Jeil Pharmaceutical Co Ltd &nbsp;13.6.1 Jeil Pharmaceutical Co Ltd Company Information &nbsp;13.6.2 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications &nbsp;13.6.3 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Jeil Pharmaceutical Co Ltd Main Business Overview &nbsp;13.6.5 Jeil Pharmaceutical Co Ltd Latest Developments &nbsp;13.7 AMO Pharma Ltd &nbsp;13.7.1 AMO Pharma Ltd Company Information &nbsp;13.7.2 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Portfolios and Specifications &nbsp;13.7.3 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 AMO Pharma Ltd Main Business Overview &nbsp;13.7.5 AMO Pharma Ltd Latest Developments 14 Research Findings and Conclusion

Report	Global Glycogen Synthase Kinase 3 Beta Market Growth 2025-2031
Selected License	Multi ID: LPI23835

Buyer Information

Order Summary